Skip to main content
TECX logo

TECX

Tectonic Therapeutic, Inc.
$35.48 -1.06 (-2.90%) At close · Jul 8
Market Cap
$669.48M
Shares
18,869,186

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$35.48 Open$36.31 Day$34.66–37.75 52W$14.39–39.53 Avg vol 30d186K Short int2.2M · 11.4% float · 16.7d Short vol47% Last earningsFeb 26, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 7
Equibles Rating blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 16.9 · calm Equity put/call 0.86
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +47%
above
Price vs 50-day avg +19%
above
RSI (14) 61
neutral
MACD trend Positive
52-week position 84%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +22%
trailing
6-month return +80%
trailing
YTD return +70%
this year
Relative strength +72%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $30 › 200d $24 — 50d above 200d
Institutional flow Distributing
3 of 112 funds reported for Jun 30 · net -45 sh shares · +1 new
Insider flow Distributing
Net -$32.0K over 90 days · 100% sells
Short interest Falling
11.41% of float · ▼ -8.1% MoM · 16.7 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
112 holders — near 2-yr high, broad support
Squeeze score 90
high risk · 0–100
Fundamentals
Strong
EPS growth +41%
Y/Y
Free cash flow $-60.3M
Balance sheet $238.8M
net cash
Quant / Vol
risk profile
Very High
Volatility 82%
annualized · 1-yr
Max drawdown −45%
past year
ATR 7.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Up next
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 7, 2026

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+47% Bullish
Price vs 50-day avg
+19% Bullish
RSI (14)
61 Neutral
MACD trend
Positive Bullish
52-week position
84% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $30 › 200d $24 — 50d above 200d
Institutional flow Distributing
3 of 112 funds reported for Jun 30 · net -45 sh shares · +1 new
Insider flow Distributing
Net -$32.0K over 90 days · 100% sells
Short interest Falling
11.41% of float · ▼ -8.1% MoM · 16.7 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
112 holders — near 2-yr high, broad support
Price context
position in its 52-week range
52-wk low $14 Now $35 · 84% 52-wk high $40
vs 200-day avg +47% vs 50-day avg +19%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TECX
Tectonic Therapeutic, Inc.
this stock
$669.48M +70.1% 11.4%
ONC
BeOne Medicines Ltd.
$436.30B -0.6% +22179.2% 887.9 0.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
$126.50B +9.9% +46.2% 29.6 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
$69.50B -14.0% +20.8% 16.2 3.2%
ARGX
Argenx SE
$57.20B +8.8% 2.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
112
% held
75.1%
Reported
3 of 112
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
122
View
Short & Settlement
Short Interest Falling
Shares short
2.2M
Days to cover
16.7d
Change
-188.8K sh
View
Short Volume
Short vol %
47%
As of
Jul 8, 2026
Short Total
View
Fails to Deliver
FTD shares
64
Value
$1.8K
As of
Jun 11, 2026
View
Off-Exchange
Off-exchange %
36.9%
Week of
May 4, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$32.0K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Net income (FY)
$-74.2M
EPS diluted
$-4.05
View
Filings
SEC Filings
Latest
8-K
Filed
Jun 10, 2026
This year
8
View
Proposed Sales
Value
$5.7K
Shares
172
Filed
Jun 30, 2026
View
Exempt Offerings
Offering
$185.0M
Filed
Feb 14, 2025
View
Earnings & Events
Earnings Calls
Last call
Feb 26, 2026
View
Investor Relations
Latest news
Tectonic Therapeutic Completes En…
Published
Jun 10, 2026
View

Performance

5D 20D 120D MTD YTD
TECX +3.2% +21.9% +79.7% +3.2% +70.1%
SPY -0.2% +0.8% +7.4% -0.2% +9.3%
vs SPY +3.4% +21.1% +72.2% +3.4% +60.8%
Key facts CIK 1681087 CUSIP 878972108 13F (30d) 2 filings 2 filers Visit website Investor relations